newsfilter
← Latest News
GlobeNewswire·

INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update

BOCA RATON, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to